Target intelligence / Profile preview

Plasmodium vesicular trafficking machinery

Molecular classification
Enzyme, Transporter, Protein complex, Lipid kinase, GTPase
01

Overview

The Plasmodium vesicular trafficking machinery is a specialized network of organelles, proteins, and lipids that the malaria parasite uses to survive and replicate within host red blood cells. This system is responsible for the synthesis, transport, and export of proteins across multiple membranes, including the parasite plasma membrane and the parasitophorous vacuole membrane (PVM). A central component is the Plasmodium translocon of exported proteins (PTEX), which acts as a gatekeeper for proteins destined for the host cell (Elsworth et al., 2014, Nature). These exported proteins are essential for remodeling the erythrocyte to facilitate nutrient uptake and for the presentation of virulence factors like PfEMP1 on the cell surface to evade the immune system (Koumandou et al., 2011, Molecular Microbiology). Drugs targeting this machinery, such as Ganaplacide (KAF156) and various PI3K/PI4K inhibitors, work by disrupting these transport processes, effectively starving the parasite or preventing it from modifying its environment (McNamara et al., 2013, Science). However, because many elements of this machinery are conserved across eukaryotes, achieving high selectivity for the parasite over the human host remains a significant therapeutic challenge (Langsley et al., 2008, Traffic).

Other names
Plasmodium secretory pathwayPlasmodium endomembrane systemPlasmodium protein export pathwayPlasmodium trafficking system
02

Mechanism of action

Inhibition of protein export via the PTEX complex, disruption of phosphoinositide signaling (PI3K/PI4K), and interference with vesicle formation and fusion mediated by Rab GTPases and SNAREs.

03

Biological functions

Protein transportVesicle-mediated transportHost cell remodelingNutrient acquisitionImmune evasionOrganelle biogenesis
04

Disease associations

Infection (Malaria)
05

Safety considerations

Off-target inhibition of human vesicular trafficking componentsHigh degree of conservation in eukaryotic secretory pathwaysPotential for rapid development of drug resistance through mutations in regulatory proteins like PfCARLHost toxicity due to interference with essential cellular transport
06

Interacting drugs

Ganaplacide (KAF156)

6 more in the full profile.

07

Biomarkers

Plasmodium falciparum histidine-rich protein 2 (HRP2)Parasite lactate dehydrogenase (pLDH)Surface expression of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1)Parasite clearance rate (PCR)

Beyond the preview

Go deeper on Plasmodium vesicular trafficking machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium vesicular trafficking machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call